From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria

Samankaltaisia teoksia

• From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria
  Tekijä: Anna-Elisabeth Minder, MD, et al.
  Julkaistu: (2026-02-01)
• Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
  Tekijä: Anna-Elisabeth Minder, et al.
  Julkaistu: (2023-04-01)
• Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
  Tekijä: Elena Di Pierro, et al.
  Julkaistu: (2022-01-01)
• New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective
  Tekijä: Cornelia Dechant, et al.
  Julkaistu: (2025-12-01)
• Protection from phototoxic injury during laparoscopic surgery in patients with erythropoietic protoporphyria
  Tekijä: Konrad Pielaciński, et al.
  Julkaistu: (2022-06-01)